BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21698700)

  • 1. Possible role for Ca2+ in the pathophysiology of the prion protein?
    Peggion C; Bertoli A; Sorgato MC
    Biofactors; 2011; 37(3):241-9. PubMed ID: 21698700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
    Sorgato MC; Bertoli A
    Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prions and their biology].
    Gasset M; Westaway D
    Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions.
    Béland M; Roucou X
    J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
    Schmitt HP
    Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical analysis of the implication of PrP in neuronal death during transmissible subacute spongiform encephalopathies: hypothesis of a PrP oligomeric channel.
    Chapron Y; Peyrin JM; Crouzy S; Jaegly A; Dormont D
    J Theor Biol; 2000 May; 204(1):103-11. PubMed ID: 10772851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
    Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
    Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation.
    Kim BH; Lee HG; Choi JK; Kim JI; Choi EK; Carp RI; Kim YS
    Brain Res Mol Brain Res; 2004 Apr; 124(1):40-50. PubMed ID: 15093684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
    Benvegnù S; Poggiolini I; Legname G
    J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intriguing nucleic-acid-binding features of mammalian prion protein.
    Silva JL; Lima LM; Foguel D; Cordeiro Y
    Trends Biochem Sci; 2008 Mar; 33(3):132-40. PubMed ID: 18243708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the natural variability of prion diseases.
    Geissen M; Krasemann S; Matschke J; Glatzel M
    Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of cerebral neurodegeneration in prion diseases.
    Tatzelt J; Schätzl HM
    FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmissible spongiform encephalopathies.
    Liemann S; Glockshuber R
    Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.